Medizinische Universität Graz - Research portal

• Go directly to the nagivation.
• Go directly to the content.

• Print view.
• German.
• Contact.
• Data entry.
• Start.
• Open Access.

Onco Track - Methods for systematic next generation oncology biomarker development

Local Subprojectlead:

Haybäck Johannes

Duration:

01.01.2011-31.12.2016

Programme:

EU (FP-7)

Subprogramme

IMI_FP7-Health.2010.4.2.9-6:Integrated data analyses and servicing.

Type of Research

applied research

Staff

Haybäck, Johannes, Project Leader

MUG Research Units

Diagnostic and Research Institute of Pathology

Project partners

Alacris Theranostics GmbH, Germany

Astrazeneca AB, Sweden

Bayer Schering Pharma AG, Germany

Boehringer Ingelheim International GmbH, Germany

Charite Universitätsmedizin Berlin, Germany

Experimental Pharmacology and Oncology GmbH, Germany

F. Hoffmann-La Roche AG, Switzerland

GABO:MI Gesellschaft für Ablauforganisation:Milliarium mbH & Co KG, Germany

International Prevention Research Institut-IPRI Management, France

Janssen Pharmaceutica N.V., Belgium

Max Planck Gesellschaft zur Förderung der Wissenschaften E.V., Germany

Merck KGAA, Germany

Pfizer LTD, United Kingdom

Technische Universität Dresden, Germany

University College, London, United Kingdom

Uppsala University, Sweden

, France

Funded by

Europäische Kommission, Rue de la Loi, Brussels, Belgium

Project results published

> A pipline within the Onco Track project for genera... Abstract book. 2014; -AACR Annual Meeting 2014 ; April 5-9, 2014; San Diego Convention Center, USA.